World's Best Scientists 2026 revealed!

D-Index & Metrics

Psychology

D-Index
70
Citations
14985
World Ranking
2300
National Ranking
1335

Frances R. Levin publication distribution in Psychology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Psychology in 2026. The highlighted bar marks where Frances R. Levin sits on this spectrum.

31–40 publications: 6 scientists 41–50 publications: 52 scientists 51–60 publications: 138 scientists 61–70 publications: 299 scientists 71–80 publications: 461 scientists 81–90 publications: 605 scientists 91–100 publications: 713 scientists 101–110 publications: 736 scientists 111–120 publications: 686 scientists 121–130 publications: 670 scientists 131–140 publications: 644 scientists 141–150 publications: 597 scientists 151–160 publications: 576 scientists 161–170 publications: 477 scientists 171–180 publications: 450 scientists 181–190 publications: 397 scientists 191–200 publications: 343 scientists 201–210 publications: 328 scientists 211–220 publications: 313 scientists 221–230 publications: 283 scientists 231–240 publications: 226 scientists 241–250 publications: 196 scientists 251–260 publications: 201 scientists 261–270 publications: 171 scientists 271–280 publications: 151 scientists 281–290 publications: 139 scientists 291–300 publications: 113 scientists 301–310 publications: 102 scientists 311–320 publications: 100 scientists 321–330 publications: 76 scientists 331–340 publications: 92 scientists 341–350 publications: 85 scientists 351–360 publications: 69 scientists 361–370 publications: 71 scientists 371–380 publications: 63 scientists 381–390 publications: 58 scientists 391–400 publications: 57 scientists 401–410 publications: 43 scientists 411–420 publications: 33 scientists 421–430 publications: 50 scientists 431–440 publications: 41 scientists 441–450 publications: 32 scientists 451–460 publications: 27 scientists 461–470 publications: 28 scientists 471–480 publications: 25 scientists 481–490 publications: 28 scientists 491–500 publications: 20 scientists 501–510 publications: 23 scientists 511–520 publications: 26 scientists 521–530 publications: 17 scientists 531–540 publications: 21 scientists 541–550 publications: 14 scientists 551–560 publications: 16 scientists 561–570 publications: 10 scientists 571–580 publications: 22 scientists 581–590 publications: 9 scientists 591–600 publications: 14 scientists 601–610 publications: 9 scientists 611–620 publications: 11 scientists 621–630 publications: 4 scientists 631–640 publications: 7 scientists 641–650 publications: 5 scientists 651–660 publications: 10 scientists 661–670 publications: 8 scientists 671–680 publications: 8 scientists 681–690 publications: 4 scientists 691–700 publications: 3 scientists 701–704 publications: 4 scientists 705+ publications: 100 scientists
31 publications 705+

This scientist: 295 publications — 87th percentile

87% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 705 publications or more.

Frances R. Levin D-index placement in Psychology in 2026

The chart shows the D-index (discipline H-index) distribution of Psychology scientists ranked by Research.com in 2026. The highlighted bar marks where Frances R. Levin sits on this spectrum.

30–31 D-Index: 398 scientists 32–33 D-Index: 702 scientists 34–35 D-Index: 671 scientists 36–37 D-Index: 659 scientists 38–39 D-Index: 641 scientists 40–41 D-Index: 671 scientists 42–43 D-Index: 617 scientists 44–45 D-Index: 558 scientists 46–47 D-Index: 495 scientists 48–49 D-Index: 487 scientists 50–51 D-Index: 445 scientists 52–53 D-Index: 390 scientists 54–55 D-Index: 408 scientists 56–57 D-Index: 345 scientists 58–59 D-Index: 325 scientists 60–61 D-Index: 321 scientists 62–63 D-Index: 248 scientists 64–65 D-Index: 290 scientists 66–67 D-Index: 218 scientists 68–69 D-Index: 219 scientists 70–71 D-Index: 215 scientists 72–73 D-Index: 183 scientists 74–75 D-Index: 169 scientists 76–77 D-Index: 132 scientists 78–79 D-Index: 137 scientists 80–81 D-Index: 120 scientists 82–83 D-Index: 112 scientists 84–85 D-Index: 86 scientists 86–87 D-Index: 101 scientists 88–89 D-Index: 83 scientists 90–91 D-Index: 77 scientists 92–93 D-Index: 70 scientists 94–95 D-Index: 78 scientists 96–97 D-Index: 58 scientists 98–99 D-Index: 53 scientists 100–101 D-Index: 57 scientists 102–103 D-Index: 48 scientists 104–105 D-Index: 53 scientists 106–107 D-Index: 46 scientists 108–109 D-Index: 24 scientists 110–111 D-Index: 35 scientists 112–113 D-Index: 27 scientists 114–115 D-Index: 32 scientists 116–117 D-Index: 31 scientists 118–119 D-Index: 22 scientists 120–121 D-Index: 16 scientists 122–123 D-Index: 24 scientists 124–125 D-Index: 18 scientists 126–127 D-Index: 11 scientists 128–129 D-Index: 19 scientists 130–131 D-Index: 10 scientists 132–133 D-Index: 16 scientists 134–135 D-Index: 10 scientists 136–137 D-Index: 12 scientists 138–139 D-Index: 8 scientists 140–141 D-Index: 5 scientists 142–143 D-Index: 12 scientists 144+ D-Index: 98 scientists
30 D-Index 144+

This scientist: 70 D-Index — 81st percentile

81% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 144 D-Index or more.

Overview

Frances R. Levin is affiliated with Columbia University in the United States. Their research mainly spans the field of Medicine, with a focus on Psychiatry and Mental Health, Public Health, Environmental and Occupational Health, Epidemiology, Pharmacology, and Cellular and Molecular Neuroscience.

The scientist's major research topics include:

  • Opioid Use Disorder Treatment
  • Attention Deficit Hyperactivity Disorder
  • Substance Abuse Treatment and Outcomes
  • Cannabis and Cannabinoid Research
  • Neurotransmitter Receptor Influence on Behavior
  • Treatment of Major Depression
  • Prenatal Substance Exposure Effects

Recent notable publications by Frances R. Levin include:

  • The HEALing (Helping to End Addiction Long-term SM) Communities Study: Protocol for a cluster randomized trial at the community level to reduce opioid overdose deaths through implementation of an integrated set of evidence-based practices (2020, Drug and Alcohol Dependence)
  • New directions in the treatment of opioid withdrawal (2020, The Lancet)
  • Prescription psychostimulants for the treatment of stimulant use disorder: a systematic review and meta-analysis (2020, Psychopharmacology)
  • Pharmacotherapeutic strategies for treating cocaine use disorder-what do we have to offer? (2020, Addiction)
  • Signaling-specific inhibition of the CB1 receptor for cannabis use disorder: phase 1 and phase 2a randomized trials (2023, Nature Medicine)

Frances R. Levin has frequently published in the following venues:

  • Drug and Alcohol Dependence (17 publications)
  • European Addiction Research (7 publications)
  • The American Journal of Drug and Alcohol Abuse (6 publications)
  • Psychiatric Services (5 publications)
  • American Journal on Addictions (4 publications)

Collaborations play a role in their work, with frequent co-authors including Edward V. Nunes, John J. Mariani, Martina Pavlicová, Nasir H. Naqvi, and Cale Basaraba.

In addition to journal publications, Frances R. Levin has contributed to book literature, including a publication by American Psychiatric Association Publishing eBooks titled The American Psychiatric Association Publishing Textbook of Substance Use Disorder Treatment (2021).

Best Publications

  • Treatment of depression in patients with alcohol or other drug dependence: a meta-analysis.

    Edward V. Nunes;Frances R. Levin

  • Rates of Psychiatric Comorbidity Among U.S. Residents with Lifetime Cannabis Dependence

    Vito Agosti;Edward Nunes;Frances Levin

  • Development of a Cascade of Care for responding to the opioid epidemic

    Arthur Robin Williams;Arthur Robin Williams;Edward V. Nunes;Edward V. Nunes;Adam Bisaga;Adam Bisaga;Frances R. Levin;Frances R. Levin

  • Dronabinol for the Treatment of Cannabis Dependence: A Randomized, Double-Blind, Placebo-Controlled Trial

    Frances R. Levin;John J. Mariani;Daniel J. Brooks;Martina Pavlicova

  • Treatment of cocaine dependent treatment seekers with adult ADHD: double-blind comparison of methylphenidate and placebo.

    Frances R. Levin;Suzette M. Evans;Daniel J. Brooks;Fatima Garawi

  • Prevalence of adult attention-deficit hyperactivity disorder among cocaine abusers seeking treatment

    Frances Rudnick Levin;Suzette M Evans;Herbert D Kleber

  • Variability in the prevalence of adult ADHD in treatment seeking substance use disorder patients: results from an international multi-center study exploring DSM-IV and DSM-5 criteria

    Geurt van de Glind;Maija Konstenius;Maarten W.J. Koeter;Katelijne van Emmerik-van Oortmerssen;Katelijne van Emmerik-van Oortmerssen

  • Treatment of methadone-maintained patients with adult ADHD: Double-blind comparison of methylphenidate, bupropion and placebo

    Frances R. Levin;Suzette M. Evans;Daniel J. Brooks;Aparna S. Kalbag

  • Methylphenidate treatment for cocaine abusers with adult attention-deficit/hyperactivity disorder: a pilot study.

    Frances R. Levin;Suzette M. Evans;David M. McDowell;Herbert D. Kleber

  • Validity of the Adult ADHD Self-Report Scale (ASRS) as a screener for adult ADHD in treatment seeking substance use disorder patients

    Geurt Van de Glind;Wim van den Brink;Maarten W.J. Koeter;Pieter Jan Carpentier

  • Changes in Mood, Cognitive Performance and Appetite in the Late Luteal and Follicular Phases of the Menstrual Cycle in Women With and Without PMDD (Premenstrual Dysphoric Disorder)

    Stephanie Collins Reed;Frances R. Levin;Suzette M. Evans

  • Psychiatric comorbidity in treatment-seeking substance use disorder patients with and without attention deficit hyperactivity disorder: results of the IASP study

    Katelijne van Emmerik-van Oortmerssen;Katelijne van Emmerik-van Oortmerssen;Geurt van de Glind;Maarten W. J. Koeter;Steve Allsop

  • Posttraumatic stress disorder and short-term outcome in early methadone treatment.

    Denise A Hien;Denise A Hien;Edward Nunes;Frances Rudnick Levin;Deborah Fraser;Deborah Fraser

  • Extended-Release Mixed Amphetamine Salts vs Placebo for Comorbid Adult Attention-Deficit/Hyperactivity Disorder and Cocaine Use Disorder: A Randomized Clinical Trial.

    Frances R. Levin;John J. Mariani;Sheila M Specker;Marc E Mooney

  • Treatment of depression in patients with opiate dependence.

    Edward V. Nunes;Maria A. Sullivan;Frances R. Levin

  • Bipolar disorder and substance abuse

    Frances R. Levin;Grace Hennessy

  • Treatment Strategies for Co-Occurring ADHD and Substance Use Disorders

    John J. Mariani;Frances R. Levin

  • Priority actions to improve the care of persons with co-occurring substance abuse and other mental disorders: a call to action.

    Charles P. O'Brien;Dennis S. Charney;Lydia Lewis;James W. Cornish

  • Developing an opioid use disorder treatment cascade: A review of quality measures.

    Arthur Robin Williams;Edward V. Nunes;Adam Bisaga;Harold A. Pincus

  • International Consensus Statement on Screening, Diagnosis and Treatment of Substance Use Disorder Patients with Comorbid Attention Deficit/Hyperactivity Disorder.

    Cleo L. Crunelle;Cleo L. Crunelle;Wim van den Brink;Franz Moggi;Maija Konstenius

  • Treatment of Cannabis Use Disorders: A Review of the Literature

    Benjamin R. Nordstrom;Frances R. Levin

  • Quantification and Comparison of Marijuana Smoking Practices: Blunts, Joints, and Pipes

    John J. Mariani;Daniel Brooks;Margaret Haney;Frances R. Levin

Frequent Co-Authors

Edward V. Nunes
Edward V. Nunes Columbia University
Adam Bisaga
Adam Bisaga Columbia University
Richard W. Foltin
Richard W. Foltin Columbia University
Wim van den Brink
Wim van den Brink University of Amsterdam
Sharlene Kaye
Sharlene Kaye University of New South Wales
Zsolt Demetrovics
Zsolt Demetrovics Flinders University
Geert Dom
Geert Dom University of Antwerp
Robert A. Schoevers
Robert A. Schoevers University Medical Center Groningen
Carl L. Hart
Carl L. Hart Columbia University
Maarten W. J. Koeter
Maarten W. J. Koeter University of Amsterdam

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing a degree in psychology opens doors to a variety of fulfilling career pathways, both online and in-person. Marriage and family therapy (MFT) is one popular specialization for those interested in helping individuals, couples, and families navigate life's challenges. To practice as an MFT, it's important to understand the specific educational and licensing requirements, which can vary by location.

For example, those looking into mft requirements in Durham must complete graduate-level education and fulfill state-specific supervised clinical experience. Similarly, there are detailed steps on how to become a marriage and family therapist in El Paso, including licensing exams and post-degree internships.

Prospective therapists interested in starting their practice in Indiana can review guidance on how to become an mft in Fort Wayne. Texas-based students can find tailored resources on how to become an mft in Fort Worth. Online psychology degrees are available nationwide, but always check state-specific licensure requirements before enrolling in a program or relocating.

Best Scientists Citing Frances R. Levin

Trending Scientists